Ruthenium-induced corneal collagen crosslinking under visible light
Source abstract
Abstract
Corneal collagen crosslinking (CXL) is a commonly used minimally invasive surgical technique to prevent the progression of corneal ectasias, such as keratoconus. Unfortunately, riboflavin/UV-A light-based CXL procedures have not been successfully applied to all patients, and result in frequent complications, such as corneal haze and endothelial damage. We propose a new method for corneal crosslinking by using a Ruthenium (Ru) based water-soluble photoinitiator and visible light (430 nm). Tris(bipyridine)ruthenium(II) ([Ru(bpy)3]2+) and sodium persulfate (SPS) mixture covalently crosslinks free tyrosine, histidine, and lysine groups under visible light (400-450 nm), which prevents UV-A light-induced cytotoxicity in an efficient and time saving collagen crosslinking procedure. In this study, we investigated the effects of the Ru/visible blue light procedure on the viability and toxicity of human corneal epithelium, limbal, and stromal cells. Then bovine corneas crosslinked with ruthenium mixture and visible light were characterized, and their biomechanical properties were compared with the customized riboflavin/UV-A crosslinking approach in the clinics. Crosslinked corneas with a ruthenium-based CXL approach showed significantly higher young's modulus compared to riboflavin/UV-A light-based method applied to corneas. In addition, crosslinked corneas with both methods were characterized to evaluate the hydrodynamic behavior, optical transparency, and enzymatic resistance. In all biomechanical, biochemical, and optical tests used here, corneas that were crosslinked with ruthenium-based approach demonstrated better results than that of corneas crosslinked with riboflavin/ UV-A. This study is promising to be translated into a non-surgical therapy for all ectatic corneal pathologies as a result of mild conditions introduced here with visible light exposure and a nontoxic ruthenium-based photoinitiator to the cornea. STATEMENT OF SIGNIFICANCE: Keratoconus, one of the most frequent corneal diseases, could be treated with riboflavin and ultraviolet light-based photo-crosslinking application to the cornea of the patients. Unfortunately, this method has irreversible side effects and cannot be applied to all keratoconus patients. In this study, we exploited the photoactivation behavior of an organoruthenium compound to achieve corneal crosslinking. Ruthenium-based organic complex under visible light demonstrated significantly better biocompatibility and superior biomechanical results than riboflavin and ultraviolet light application. This study promises to translate into a new fast, efficient non-surgical therapy option for all ectatic corneal pathologies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Corneal surgery and disorders · Corneal Surgery and Treatments · Glaucoma and retinal disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Current treatment options for corneal ectasia10.1097/ICU.0b013e3281a7ecaa ↗
2. A review of keratoconus: diagnosis, pathophysiology, and genetics10.1016/j.survophthal.2017.06.009 ↗
3. The keratoconus enigma: a review with emphasis on pathogenesis10.1016/j.jtos.2020.03.006 ↗
4. Measurement of Quality of Life in Keratoconus10.1097/ICO.0000000000002170 ↗
5. K. Group of Panelists for the Global Delphi Panel of, D. Ectatic, Global consensus on keratoconus and ectatic diseases10.1097/ICO.0000000000000408 ↗
6. Current perspectives in the management of keratoconus with contact lenses10.1038/s41433-020-1065-z ↗
7. Efficacy of Corneal Collagen Cross-Linking for the Treatment of Keratoconus: a Systematic Review and Meta-Analysis10.1097/ICO.0000000000000723 ↗
8. Lamellar Keratoplasty for Advanced Keratoconus10.1097/APO.0000000000000338 ↗
9. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles10.1016/j.jtos.2013.01.002 ↗
10. Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas10.1016/j.exer.2012.09.005 ↗
11. Variation in the Lysyl Oxidase (LOX) Gene Is Associated with Keratoconus in Family-Based and Case-Control Studies10.1167/iovs.11-9268 ↗
12. Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA)10.1167/iovs.09-3738 ↗
13. Corneal collagen cross-linking (CXL) in thin corneas10.1186/s40662-015-0025-3 ↗
14. Permanent Corneal Haze After Riboflavin-UVA-induced Cross-linking in Keratoconus
15. Persistent Corneal Edema after Collagen Cross-Linking for Keratoconus10.1016/j.ajo.2012.06.005 ↗
16. Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review10.1097/ICO.0b013e31823cbeb1 ↗
17. Corneal Cross-Linking: current USA Status: report From the Cornea Society10.1097/ICO.0000000000001707 ↗
18. Corneal crosslinking: current protocols and clinical approach10.1016/j.jcrs.2019.06.027 ↗
19. Novel corneal crosslinking technique with eosin-Y and visible light10.1111/j.1755-3768.2019.5148 ↗
20. Corneal crosslinking with rose bengal and green light: efficacy and safety evaluation10.1097/ICO.0000000000000916 ↗
21. Corneal Cross-Linking With Verteporfin and Nonthermal Laser Therapy10.1097/ICO.0000000000001473 ↗
22. Ruthenium(Ii) and Osmium(Ii) Bis(Terpyridine) Complexes in Covalently-Linked Multicomponent Systems - Synthesis, Electrochemical-Behavior, Absorption-Spectra, and Photochemical and Photophysical Properties10.1021/cr00028a006 ↗
23. Chemistry for the analysis of protein–protein interactions: rapid and efficient cross-linking triggered by long wavelength light10.1073/pnas.96.11.6020 ↗
24. Oxygen sensor based on the fluorescence quenching of a ruthenium complex immobilized in a biocompatible poly(ethylene glycol) hydrogel10.1109/JSEN.2004.837502 ↗
25. Facile and rapid ruthenium mediated photo-crosslinking of Bombyx mori silk fibroin10.1039/C4TB00698D ↗
26. Rapid Photocrosslinking of Silk Hydrogels with High Cell Density and Enhanced Shape Fidelity10.1002/adhm.201901667 ↗
27. Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue10.1016/j.biomaterials.2009.08.039 ↗
28. Multipotency expression of human adipose stem cells in filament-like alginate and gelatin derivative hydrogel fabricated through visible light-initiated crosslinking
29. Ruthenium-cross-linked hydrogels for rapid, visible-light protein release Teresa10.1016/bs.mie.2019.04.017 ↗
30. Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue10.1016/j.biomaterials.2010.12.010 ↗
31. Light-Activated Decellularized Extracellular Matrix-Based Bioinks for Volumetric Tissue Analogs at the Centimeter Scale
32. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light10.1073/pnas.96.11.6020 ↗
33. Chitosan-anthracene hydrogels as controlled stiffening networks10.1016/j.ijbiomac.2021.06.023 ↗
34. Androgen Suppresses Hyperosmolarity-Induced Inflammatory Mediators in Human Corneal Epithelial Cells10.1097/ICO.0000000000002291 ↗
35. Culture systems for pluripotent stem cells10.1263/jbb.100.12 ↗
36. Visible-light-induced synthesis of pH-responsive composite hydrogels for controlled delivery of the anticonvulsant drug pregabalin10.1016/j.actbio.2014.09.018 ↗
37. Chitosan-anthracene hydrogels as controlled stiffening networks10.1016/j.ijbiomac.2021.06.023 ↗
38. An all-aqueous approach for physical immobilization of PEG-lipid microgels on organoid surfaces
39. Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells10.1016/j.mtbio.2019.100006 ↗
40. Customized Corneal Cross-linking: one-Year Results10.1016/j.ajo.2016.02.029 ↗
41. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking10.1016/S0886-3350(03)00407-3 ↗
42. SpringerLink, New Frontiers for the Treatment of Keratoconus
43. Optimization of a GelatinPotassium Phosphate Aqueous Two-Phase System for the Preparation of Hydrogel Microspheres10.1007/s11837-019-03328-8 ↗
44. Multifunctional alginate-based hydrogel with reversible crosslinking for controlled therapeutics delivery10.1016/j.ijbiomac.2020.02.042 ↗
45. Anatomy and morphology of the cornea of bovine eyes from a slaughterhouse10.1139/z95-253 ↗
46. Photophysics, Photochemistry and Solar-Energy Conversion with Tris(Bipyridyl)Ruthenium(Ii) and Its Analogs10.1016/0010-8545(82)85003-0 ↗
47. Laboratory Measurement of the Absorption Coefficient of Riboflavin for Ultraviolet Light (365nm)10.3928/1081597X-20100604-01 ↗
48. Critical media attributes in E-beam sterilization of corneal tissue10.1016/j.actbio.2021.10.033 ↗
49. Organoruthenium(II) Complexes Ameliorates Oxidative Stress and Impedes the Age Associated Deterioration in Caenorhabditis elegans through JNK-1/DAF-16 Signalling10.1038/s41598-018-25984-7 ↗
50. Ki67 is a promising molecular target in the diagnosis of cancer10.3892/mmr.2014.2914 ↗
51. Corneal cross-linking in keratoconus using the standard and rapid treatment protocol: differences in demarcation line and 12-month outcomes10.1167/iovs.14-15444 ↗
52. Effect of irradiation time on riboflavin-ultraviolet-A collagen crosslinking in rabbit sclera10.1016/j.jcrs.2013.02.055 ↗
53. What is Considered a Variation of Biomechanical Parameters in Tensile Tests of Collagen-Rich Human Soft Tissues? - Critical Considerations Using the Human Cranial Dura Mater as a Representative Morpho-Mechanic Model
54. Chondroitin sulfate-based biocompatible crosslinker restores corneal mechanics and collagen alignment10.1167/iovs.16-21292 ↗
55. Biomechanical properties of corneal tissue after ultraviolet-A-riboflavin crosslinking10.1016/j.jcrs.2013.01.026 ↗
56. Increased resistance of crosslinked cornea against enzymatic digestion10.1080/02713680490513182 ↗
57. Photochemical activation increases the porcine corneal stiffness and resistance to collagenase digestion10.1016/j.exer.2014.04.008 ↗
58. Photovoltaic neurointerface based on aluminum antimonide nanocrystals10.1038/s43246-021-00123-4 ↗
59. An investigation of the effects of riboflavin concentration on the efficacy of corneal cross-linking using an enzymatic resistance model in porcine corneas10.1167/iovs.17-22994 ↗
60. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics10.1016/j.addr.2006.07.024 ↗
61. Oxygen Kinetics During Corneal Cross-linking With and Without Supplementary Oxygen10.1016/j.ajo.2020.11.001 ↗
62. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications10.1111/cxo.12203 ↗
63. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro10.1159/000074071 ↗
64. Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A10.1007/s00417-012-2101-x ↗
65. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking10.1016/j.ejpb.2021.02.012 ↗
66. The importance of measuring intraocular pressure using a tonometer in order to estimate the postmortem interval10.1097/PAF.0b013e3181dd7933 ↗
67. Post-mortem corneal thickness measurements with a portable optical coherence tomography system: a reliability study
68. Contact Lens-Assisted Collagen Cross-Linking (CACXL): a New Technique for Cross-Linking Thin Corneas10.3928/1081597X-20140523-01 ↗
69. Enhancing rose bengal-photosensitized protein crosslinking in the cornea10.1167/iovs.19-26604 ↗
70. A rabbit model of corneal Ectasia generated by treatment with collagenase type II10.1186/s12886-018-0760-z ↗